Inspired by the Alheimer's Association's nationwide fundraising event hosted annually on the summer solstice, Charles River’s Longest Day was a truly collaborative effort and promoted Alzheimer’s disease education, brain health and physical activity at our sites globally.
Charles River has acquired Celsis International Ltd, a leading provider of rapid microbial detection systems for quality control testing in the biopharmaceutical and consumer products industries. The combination of Charles River and Celsis will drive significant value for our clients’ in-process and product release testing needs across a broad range of microbial detection applications.
ChanTest, a Charles River company, in collaboration with the FDA, is developing high-throughput assays to evaluate the pharmacology of tobacco product constituents and project their physiological impact.
We are pleased to announce the appointment of Joseph Murphy, PhD, and Martin Graf, PhD, to the positions of Director and Associate Director of Science and R&D Operations, respectively, at our oncology-focused site in North Carolina.
We are excited to announce our newly available 36-plex mouse and 22-plex rat ProcartaPlex™ cytokine and chemokine immunoassays for discovery studies.
Charles River has recently validated the cuprizone model for the examination of both demyelination and remyelination for studies in multiple sclerosis.
Using novel tools such as kinematic gait analysis, we have validated several neuropathic and peripheral neuroinflammatory pain models to support the development of therapies which target these conditions.
We now offer a hind limb ischemia model of peripheral stroke, augmenting our existing selection of vascular stroke models, available study paradigms and types of CNS injury.
We are pleased to announce that Charles River Campus eLearning has been accredited for the provision of mandatory UK Home Office Modular training, in conjunction with certified classroom training.
Maintaining the security and integrity of your cell banks is our priority. We store cell banks at -70 °C or in vapor-phase liquid nitrogen in a controlled-access area and take a multilayered approach to ensure the security and performance of the cell storage facility.